Quantitative Analysis of Global Biopharmaceutical Manufacturing


USD 3,950.00

* Required Fields

USD 3,950.00


Be the first to review this product

This strategic analysis service provides detailed analysis of world biopharmaceutical manufacturing and includes both contract and captive manufacturing. The service in powerpoint format (approximately 116 slides) focuses not just only on the quantitative aspects of biopharmaceutical manufacturing but also on strategies for differentiation amongst companies in the market or those wishing to enter the market.

Table of Contents

Quantitative Analysis of Global Biopharmaceutical Manufacturing, Quantitative Analysis of Global Biopharmaceutical ManufacturingOverviewOverviewResearch Scope and MethodologyResearch Scope and MethodologyIntroduction and BackgroundIntroduction to the Biopharmaceutical IndustryWhat are Biopharmaceuticals?Why BiopharmaceuticalsCurrent Technologies and ApplicationsMarket SegmentationsMarket DynamicsIndustry ChallengesMajor Challenges and StrategiesKey Market TrendsKey Technology TrendsKey Market DriversKey Market RestraintsIndustry OutlookIndustry ReviewCapacity Forecasts - SupplyKey Market Engineering MeasurementsForecast AssumptionsTotal Manufacturing Capacity ForecastsTotal Manufacturing Capacity AnalysisCMO vs Captive Manufacturing Capacity ForecastsCaptive Manufacturing CapacityKey Market Engineering MeasurementsTotal Captive Manufacturing Capacity ForecastsCaptive Manufacturing Capacities AnalysisContract Manufacturing CapacityKey Market Engineering MeasurementsTotal Contract Manufacturing Capacity ForecastsContract Manufacturing Capacities AnalysisDemand Forecasts for Manufacturing CapacityKey Market Drivers for Capacity-DemandKey Issues for Capacity Demand Key Market Engineering MeasurementsTotal Manufacturing Capacity Demand ForecastsManufacturing Capacities Demand AnalysisCapacity Demand in North America and EuropeSupply-Demand Balance in Biopharmaceutical ManufacturingCapacity Supply and Utilisation CurvesIndustry Capacity Utilisation (2003-2011)Industry Capacity Utilisation AnalysisImplications of Over CapacityStrategic Analysis and RecommendationsBiopharmaceutical Industry is at Growth PhaseStrategic Anticipation“I Think It Might Happen” Potential Threats to BiopharmaceuticalsMarket Potential in the Biopharmaceutical IndustryCurrent and Future Status of the IndustryThree Levels of Key Strategies Pricing of BiopharmaceuticalsWhat can be Expected in the Future?Meeting the ChallengeFrost & Sullivan AwardsFrost & Sullivan AwardsMarket Leadership Award of the YearCustomer Value Leadership Award of the YearMarket penetration Leadership Award of the YearCompetitive Strategy Leadership Award of the YearGrowth Strategy Leadership Award of the YearKey Industry ParticipantsIndustry ParticipantsDecision Support DatabasesDecision Support DatabasesAbout Frost & SullivanOur TeamConsulting Capabilities

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.